![]() |
Aurania Finds New Epithermal Target: Gold Found In StreamsAurania Resources reported on a new epithermal target called Kuripan in its Lost Cities – Cutucu Project in southeastern Ecuador Research, News & Market Data on Aurania Resources |
![]() |
Cocrystal up 100% on plans of a new antiviral drug developmentCocrystal has made progress on its Covid-19 antiviral drug candidates and plans to expand development Research, News & Market Data on Cocrystal Pharma |
![]() |
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung CancerGenprex announced it has commenced clinical trial site recruitment for its upcoming Acclaim-2 clinical trial for the treatment of non-small cell lung cancer Research, News & Market Data on Genprex |
![]() |
Comtech Telecommunications Corp. Awarded $6.5 Million of Funding for Cyber Training SolutionsComtech Telecommunications announced that during its third quarter of fiscal 2021, its Government Solutions segment was awarded an additional $6.5 million of funding for its Joint Cyber Analysis Course Training solutions Research, News & Market Data on Comtech |
![]() |
ACCO Brands Corporation Declares Quarterly DividendACCO Brands announced that its board of directors has declared a quarterly cash dividend of $0.065 per share Research, News & Market Data on ACCO Brands |
![]() |
electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore SapphireelectroCore announced the U.S. Department of Veterans Affairs is starting an investigator-initiated study of the use of gammaCore Sapphire™ non-invasive vagus nerve stimulation (nVNS) for the treatment of post-traumatic headache |
![]() |
Lineage Cell Therapeutics To Report First Quarter 2021 Financial Results And Provide Business Update On May 13, 2021Lineage Cell Therapeutics announced that it will report its first quarter 2021 financial and operating results on Thursday, May 13, 2021 Research, News & Market Data on Lineage Cell Therapeutics |
Stay up to date. Follow us:
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |